2023-12-012024-11-302024-11-30false08314969F&A HEALTH LTD2025-11-2786210falseiso4217:GBPxbrli:pure083149692023-11-30083149692024-11-30083149692023-12-012024-11-30083149692022-11-30083149692023-11-30083149692022-12-012023-11-3008314969bus:SmallEntities2023-12-012024-11-3008314969bus:AuditExempt-NoAccountantsReport2023-12-012024-11-3008314969bus:FullAccounts2023-12-012024-11-3008314969bus:PrivateLimitedCompanyLtd2023-12-012024-11-3008314969core:WithinOneYear2024-11-3008314969core:AfterOneYear2024-11-3008314969core:WithinOneYear2023-11-3008314969core:AfterOneYear2023-11-3008314969core:ShareCapital2024-11-3008314969core:SharePremium2024-11-3008314969core:RevaluationReserve2024-11-3008314969core:OtherReservesSubtotal2024-11-3008314969core:RetainedEarningsAccumulatedLosses2024-11-3008314969core:ShareCapital2023-11-3008314969core:SharePremium2023-11-3008314969core:RevaluationReserve2023-11-3008314969core:OtherReservesSubtotal2023-11-3008314969core:RetainedEarningsAccumulatedLosses2023-11-3008314969core:LandBuildings2024-11-3008314969core:PlantMachinery2024-11-3008314969core:Vehicles2024-11-3008314969core:FurnitureFittings2024-11-3008314969core:OfficeEquipment2024-11-3008314969core:NetGoodwill2024-11-3008314969core:IntangibleAssetsOtherThanGoodwill2024-11-3008314969core:ListedExchangeTraded2024-11-3008314969core:UnlistedNon-exchangeTraded2024-11-3008314969core:LandBuildings2023-11-3008314969core:PlantMachinery2023-11-3008314969core:Vehicles2023-11-3008314969core:FurnitureFittings2023-11-3008314969core:OfficeEquipment2023-11-3008314969core:NetGoodwill2023-11-3008314969core:IntangibleAssetsOtherThanGoodwill2023-11-3008314969core:ListedExchangeTraded2023-11-3008314969core:UnlistedNon-exchangeTraded2023-11-3008314969core:LandBuildings2023-12-012024-11-3008314969core:PlantMachinery2023-12-012024-11-3008314969core:Vehicles2023-12-012024-11-3008314969core:FurnitureFittings2023-12-012024-11-3008314969core:OfficeEquipment2023-12-012024-11-3008314969core:NetGoodwill2023-12-012024-11-3008314969core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3008314969core:ListedExchangeTraded2023-12-012024-11-3008314969core:UnlistedNon-exchangeTraded2023-12-012024-11-3008314969core:MoreThanFiveYears2023-12-012024-11-3008314969core:Non-currentFinancialInstruments2024-11-3008314969core:Non-currentFinancialInstruments2023-11-3008314969dpl:CostSales2023-12-012024-11-3008314969dpl:DistributionCosts2023-12-012024-11-3008314969core:LandBuildings2023-12-012024-11-3008314969core:PlantMachinery2023-12-012024-11-3008314969core:Vehicles2023-12-012024-11-3008314969core:FurnitureFittings2023-12-012024-11-3008314969core:OfficeEquipment2023-12-012024-11-3008314969dpl:AdministrativeExpenses2023-12-012024-11-3008314969core:NetGoodwill2023-12-012024-11-3008314969core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3008314969dpl:GroupUndertakings2023-12-012024-11-3008314969dpl:ParticipatingInterests2023-12-012024-11-3008314969dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-012024-11-3008314969core:ListedExchangeTraded2023-12-012024-11-3008314969dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-012024-11-3008314969core:UnlistedNon-exchangeTraded2023-12-012024-11-3008314969dpl:CostSales2022-12-012023-11-3008314969dpl:DistributionCosts2022-12-012023-11-3008314969core:LandBuildings2022-12-012023-11-3008314969core:PlantMachinery2022-12-012023-11-3008314969core:Vehicles2022-12-012023-11-3008314969core:FurnitureFittings2022-12-012023-11-3008314969core:OfficeEquipment2022-12-012023-11-3008314969dpl:AdministrativeExpenses2022-12-012023-11-3008314969core:NetGoodwill2022-12-012023-11-3008314969core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3008314969dpl:GroupUndertakings2022-12-012023-11-3008314969dpl:ParticipatingInterests2022-12-012023-11-3008314969dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-012023-11-3008314969core:ListedExchangeTraded2022-12-012023-11-3008314969dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-012023-11-3008314969core:UnlistedNon-exchangeTraded2022-12-012023-11-3008314969core:NetGoodwill2024-11-3008314969core:IntangibleAssetsOtherThanGoodwill2024-11-3008314969core:LandBuildings2024-11-3008314969core:PlantMachinery2024-11-3008314969core:Vehicles2024-11-3008314969core:FurnitureFittings2024-11-3008314969core:OfficeEquipment2024-11-3008314969core:AfterOneYear2024-11-3008314969core:WithinOneYear2024-11-3008314969core:ListedExchangeTraded2024-11-3008314969core:UnlistedNon-exchangeTraded2024-11-3008314969core:ShareCapital2024-11-3008314969core:SharePremium2024-11-3008314969core:RevaluationReserve2024-11-3008314969core:OtherReservesSubtotal2024-11-3008314969core:RetainedEarningsAccumulatedLosses2024-11-3008314969core:NetGoodwill2023-11-3008314969core:IntangibleAssetsOtherThanGoodwill2023-11-3008314969core:LandBuildings2023-11-3008314969core:PlantMachinery2023-11-3008314969core:Vehicles2023-11-3008314969core:FurnitureFittings2023-11-3008314969core:OfficeEquipment2023-11-3008314969core:AfterOneYear2023-11-3008314969core:WithinOneYear2023-11-3008314969core:ListedExchangeTraded2023-11-3008314969core:UnlistedNon-exchangeTraded2023-11-3008314969core:ShareCapital2023-11-3008314969core:SharePremium2023-11-3008314969core:RevaluationReserve2023-11-3008314969core:OtherReservesSubtotal2023-11-3008314969core:RetainedEarningsAccumulatedLosses2023-11-3008314969core:NetGoodwill2022-11-3008314969core:IntangibleAssetsOtherThanGoodwill2022-11-3008314969core:LandBuildings2022-11-3008314969core:PlantMachinery2022-11-3008314969core:Vehicles2022-11-3008314969core:FurnitureFittings2022-11-3008314969core:OfficeEquipment2022-11-3008314969core:AfterOneYear2022-11-3008314969core:WithinOneYear2022-11-3008314969core:ListedExchangeTraded2022-11-3008314969core:UnlistedNon-exchangeTraded2022-11-3008314969core:ShareCapital2022-11-3008314969core:SharePremium2022-11-3008314969core:RevaluationReserve2022-11-3008314969core:OtherReservesSubtotal2022-11-3008314969core:RetainedEarningsAccumulatedLosses2022-11-3008314969core:AfterOneYear2023-12-012024-11-3008314969core:WithinOneYear2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:CostValuation2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3008314969core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3008314969core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3008314969core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3008314969core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3008314969core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3008314969core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3008314969core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3008314969core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3008314969core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3008314969core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3008314969core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3008314969core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3008314969core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3008314969core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3008314969core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3008314969core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3008314969core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3008314969core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3008314969bus:Director12023-12-012024-11-30

F&A HEALTH LTD

Registered Number
08314969
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2024

F&A HEALTH LTD
Company Information
for the year from 1 December 2023 to 30 November 2024

Director

REHMAN, Anib

Registered Address

16 Regent Street
Nottingham
NG1 5BQ

Registered Number

08314969 (England and Wales)
F&A HEALTH LTD
Balance Sheet as at
30 November 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets365,61299,514
65,61299,514
Current assets
Debtors657,710460,710
Cash at bank and on hand135,063282,862
792,773743,572
Creditors amounts falling due within one year(120,992)(132,680)
Net current assets (liabilities)671,781610,892
Total assets less current liabilities737,393710,406
Creditors amounts falling due after one year(84,908)(100,297)
Net assets652,485610,109
Capital and reserves
Called up share capital22
Profit and loss account652,483610,107
Shareholders' funds652,485610,109
The financial statements were approved and authorised for issue by the Director on 27 November 2025, and are signed on its behalf by:
REHMAN, Anib
Director
Registered Company No. 08314969
F&A HEALTH LTD
Notes to the Financial Statements
for the year ended 30 November 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
2.Average number of employees

20242023
Average number of employees during the year1810
3.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 December 2389,200132,98765,940288,127
At 30 November 2489,200132,98765,940288,127
Depreciation and impairment
At 01 December 2389,20040,10359,310188,613
Charge for year-27,2726,63033,902
At 30 November 2489,20067,37565,940222,515
Net book value
At 30 November 24-65,612-65,612
At 30 November 23-92,8846,63099,514
4.Related party transactions
During the year and at the year end, the company had the following balances with related entities: • Shawanna Investments owed £527,000 to F&A Health Ltd. • Pristine Property Ltd owed £118,210 to F & A Health Ltd. All intercompany balances are unsecured, interest-free and repayable on demand. During the year the company also recharged costs totalling £140,000 to Park Aesthetics, a related entity.